Dramatic dysbalancing of the Wnt pathway in breast cancers

[1]  Edwin Wang,et al.  Network Analysis Reveals A Signaling Regulatory Loop in the PIK3CA-mutated Breast Cancer Predicting Survival Outcome , 2017, Genom. Proteom. Bioinform..

[2]  T. Izumi,et al.  Analysis of RNA expression of normal and cancer tissues reveals high correlation of COP9 gene expression with respiratory chain complex components , 2016, BMC Genomics.

[3]  E. Verheyen,et al.  Mammary Development and Breast Cancer: A Wnt Perspective , 2016, Cancers.

[4]  G. Veenstra,et al.  Tissue- and stage-specific Wnt target gene expression is controlled subsequent to β-catenin recruitment to cis-regulatory modules , 2016, Development.

[5]  Su-In Lee,et al.  Identifying Network Perturbation in Cancer , 2016, bioRxiv.

[6]  A. Butte,et al.  Systematic pan-cancer analysis of tumour purity , 2015, Nature Communications.

[7]  J. Herman,et al.  Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth , 2015, Oncotarget.

[8]  G. Kempermann.  Faculty Opinions recommendation of Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. , 2015 .

[9]  Jun S. Liu,et al.  The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.

[10]  K. Tomczak,et al.  The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge , 2015, Contemporary oncology.

[11]  E. Wang,et al.  Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data. , 2014, Seminars in cancer biology.

[12]  T. Lumley,et al.  gplots: Various R Programming Tools for Plotting Data , 2015 .

[13]  V. Katanaev,et al.  Targeting the Wnt pathways for therapies , 2014, Molecular and Cellular Therapies.

[14]  G. Schulte,et al.  WNT/Frizzled signalling: receptor–ligand selectivity with focus on FZD‐G protein signalling and its physiological relevance: IUPHAR Review 3 , 2014, British journal of pharmacology.

[15]  Leng Han,et al.  Gene co-expression network analysis reveals common system-level properties of prognostic genes across cancer types , 2014, Nature Communications.

[16]  Angelo Andriulli,et al.  Loss of Connectivity in Cancer Co-Expression Networks , 2014, PloS one.

[17]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[18]  Chun-Yu Chuang,et al.  Visual gene-network analysis reveals the cancer gene co-expression in human endometrial cancer , 2014, BMC Genomics.

[19]  L. O’Driscoll,et al.  Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis. , 2013, Carcinogenesis.

[20]  A. Richardson,et al.  SOX9 Regulates Low Density Lipoprotein Receptor-related Protein 6 (LRP6) and T-cell Factor 4 (TCF4) Expression and Wnt/β-catenin Activation in Breast Cancer* , 2013, The Journal of Biological Chemistry.

[21]  M. Moran,et al.  The human phosphotyrosine signaling network: Evolution and hotspots of hijacking in cancer , 2012, Genome research.

[22]  Hans Clevers,et al.  Wnt/β-Catenin Signaling and Disease , 2012, Cell.

[23]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[24]  Cun-Quan Zhang,et al.  Predicting glioblastoma prognosis networks using weighted gene co-expression network analysis on TCGA data , 2012, BMC Bioinformatics.

[25]  V. Katanaev,et al.  Yellow submarine of the Wnt/Frizzled signaling: submerging from the G protein harbor to the targets. , 2011, Biochemical pharmacology.

[26]  K. Zhang,et al.  FZD7 has a critical role in cell proliferation in triple negative breast cancer , 2011, Oncogene.

[27]  P. Cowin,et al.  Key signaling nodes in mammary gland development and cancer: β-catenin , 2010, Breast Cancer Research.

[28]  G. Bu,et al.  LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy , 2010, Proceedings of the National Academy of Sciences.

[29]  Rodrigo Assar,et al.  Genome-wide identification of new Wnt/β-catenin target genes in the human genome using CART method , 2010, BMC Genomics.

[30]  Gary D Bader,et al.  NetPath: a public resource of curated signal transduction pathways , 2010, Genome Biology.

[31]  Edwin Wang,et al.  Signaling network analysis of ubiquitin-mediated proteins suggests correlations between the 26S proteasome and tumor progression. , 2009, Molecular bioSystems.

[32]  J. Jessen.  Noncanonical Wnt signaling in tumor progression and metastasis. , 2009, Zebrafish.

[33]  Arjun Deb,et al.  Secreted frizzled related protein 2 protects cells from apoptosis by blocking the effect of canonical Wnt3a. , 2007, Journal of molecular and cellular cardiology.

[34]  V. Katanaev,et al.  Trimeric G protein-dependent signaling by Frizzled receptors in animal development. , 2008, Frontiers in bioscience : a journal and virtual library.

[35]  E. Dahl,et al.  Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis. , 2008, Carcinogenesis.

[36]  M. Moasser.  The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis , 2007, Oncogene.

[37]  Hans Clevers,et al.  Mining the Wnt pathway for cancer therapeutics , 2007, Nature Reviews Drug Discovery.

[38]  R. Holcombe,et al.  Regulation of norrin receptor frizzled-4 by Wnt2 in colon-derived cells , 2007, BMC Cell Biology.

[39]  G. Turashvili,et al.  Wnt Signaling Pathway in Mammary Gland Development and Carcinogenesis , 2007, Pathobiology.

[40]  M. Ozturk,et al.  Redundant expression of canonical Wnt ligands in human breast cancer cell lines. , 2006, Oncology reports.

[41]  S. Bergmann,et al.  Comparative Gene Expression Analysis by a Differential Clustering Approach: Application to the Candida albicans Transcription Program , 2005, PLoS genetics.

[42]  R. Nusse,et al.  The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.

[43]  Irina Klaman,et al.  Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors. , 2004, International journal of oncology.

[44]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[45]  Christian Pilarsky,et al.  WIF1, a component of the Wnt pathway, is down‐regulated in prostate, breast, lung, and bladder cancer , 2003, The Journal of pathology.

[46]  Hans Clevers,et al.  Caught up in a Wnt storm: Wnt signaling in cancer. , 2003, Biochimica et biophysica acta.

[47]  M. Emi,et al.  Amplification, up‐regulation and over‐expression of DVL‐1, the human counterpart of the Drosophila disheveled gene, in primary breast cancers , 2003, Cancer science.

[48]  P. Bendahl,et al.  Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. , 2002, Cancer research.

[49]  H. Varmus,et al.  Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer , 2000, Oncogene.

[50]  Å. Borg,et al.  Involvement of adenomatous polyposis coli (APC)/β-catenin signalling in human breast cancer , 2000 .

[51]  Lam,et al.  Reduced expression of APC and DCC gene protein in breast cancer , 1999, Histopathology.

[52]  C. Nguyen,et al.  Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes , 1999, Oncogene.

[53]  S. Linder,et al.  Up‐regulation of human secreted frizzled homolog in apoptosis and its down‐regulation in breast tumors , 1998, International journal of cancer.

[54]  P. Leder,et al.  Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice , 1997, Oncogene.